Cholera and other types of vibriosis: A story of human pandemics and oysters on the half shell

Clinical Infectious Diseases

Volumn 37, Issue 2, 2003, Pages 272-280

  Morris Jr , J Glenn ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLERA TOXIN; COTRIMOXAZOLE; DOXYCYCLINE; FURAZOLIDONE; HEMOLYSIN; TETRACYCLINE;

AQUATIC ENVIRONMENT; CHOLERA; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE TRANSMISSION; EATING; EPIDEMIC; FOOD; FOOD INTAKE; FOOD SAFETY; GASTROENTERITIS; IMMUNE DEFICIENCY; LIVER DISEASE; NONHUMAN; OYSTER; PRIORITY JOURNAL; REVIEW; SEA FOOD; SEPSIS; SEPTICEMIA; SHELLFISH; SPECIES DIFFERENCE; STRAIN DIFFERENCE; VIBRIO CHOLERAE; VIBRIO PARAHAEMOLYTICUS; VIBRIO VULNIFICUS; WATER SUPPLY; WOUND INFECTION; ANIMAL; ARTICLE; FOOD CONTROL; FOOD POISONING; GRAM NEGATIVE INFECTION; HUMAN; MICROBIOLOGY;

ANIMALS; CHOLERA; DISEASE OUTBREAKS; FOOD MICROBIOLOGY; FOOD POISONING; HUMANS; OSTREIDAE; SHELLFISH; VIBRIO CHOLERAE; VIBRIO INFECTIONS; VIBRIO PARAHAEMOLYTICUS; VIBRIO VULNIFICUS;

EID: 0042267302     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/375600     Document Type: Review

References (68)

1. Wright AC, Hill RT, Johnson JA, Roghman M-C, Colwell RR, Morris JG Jr. Distribution of Vibrio vulnificus in the Chesapeake Bay. Appl Environ Microbiol 1996; 62:717-24.
2. Heidelberg JF, Heidelberg KB, Colwell RR. Seasonality of Chesapeake Bay bacterioplankton species. Appl Environ Microbiol 2002; 68:5488-97.
3. Motes ML, DePaola A, Cook DW, et al. Influence of water temperature and salinity on Vibrio vulnificus in northern Gulf and Atlantic Coast oysters. Appl Environ Microbiol 1998; 64:1459-65.
4. Cook DW, Oleary P, Hunsucker JC, et al. Vibrio vulnificus and Vibrio parahaemolyticus in US retail shell oysters: a national survey from June 1998 to July 1999. J Food Prot 2002; 65:79-87.
5. Hoge CW, Watsky D, Peeler RN, Libonati JP, Israel E, Morris JG Jr. Epidemiology and spectrum of Vibrio infections in a Chesapeake Bay community. J Infect Dis 1989; 160:985-93.
6. Hughes JM, Hollis DG, Gangarosa EJ, Weaver RE. Non-cholera vibrio infections in the United States. Ann Intern Med 1978; 88:602-6.
7. Ko W-C, Chuang Y-C, Huang G-C, Hsu S-Y. Infections due to non-O1 Vibrio cholerae in southern Taiwan: predominance in cirrhotic patients. Clin Infect Dis 1998; 27:774-80.
8. Levine WC, Griffin PM. Vibrio infections on the Gulf Coast: results of first year of regional surveillance. Gulf Coast Vibrio Working Group. J Infect Dis 1993; 167:479-83.
9. Lee WC, Lee MJ, Kim JS, Park SY. Foodborne illness outbreaks in Korea and Japan studied retrospectively. J Food Prot 2001; 64:899-902.
10. Blake PA, Merson MH, Weaver RE, Hollis DG, Heublein PC. Disease caused by a marine Vibrio: clinical characteristics and epidemiology. N Engl J Med 1979; 300:1-5.
11. Cano RJ, Tiefenbrunner F, Ubaldi M, et al. Sequence analysis of bacterial DNA in the colon and stomach of the Tyrolean Iceman. Am J Phys Anthropol 2000; 112:297-309.
12. World Health Organization. Cholera, 2001. Wkly Epidemiol Rec 2002; 77:257-65.
13. Kaper JB, Morris JG Jr, Levine MM. Cholera. Clin Microbiol Rev 1995; 8:48-86.
14. Nair GB, Ramamurthy T, Bhattacharya SK, et al. Spread of Vibrio cholerae O139 Bengal in India. J Infect Dis 1994; 169:1029-34.
15. Large epidemic of cholera-like disease in Bangladesh caused by Vibrio cholerae O139 synonym Bengal. International Center for Diarrheal Disease Research, Bangladesh, Cholera Working Group. Lancet 1993; 342:387-90.
16. Bik EM, Gouw RD, Mooi FR. DNA fingerprinting of Vibrio cholerae strains with a novel insertion sequence element: a tool to identify epidemic strains. J Clin Microbiol 1996; 34:1453-61.
17. Li M, Shimada T, Morris JG Jr, Sulakvelidze A, Sozhamannan S. Evidence for the emergence of non-O1 and non-O139 Vibrio cholerae strains with pathogenic potential by exchange of O-antigen biosynthesis regions. Infect Immun 2002; 70:2441-53.
18. Dalsgaard A, Serichantalergs O, Forslund A, et al. Clinical and environmental isolates of Vibrio cholerae O141 carry the CTX phage and the genes encoding the toxin-coregulated pili. J Clin Microbiol 2001; 39:4086-92.
19. Albert J, Morris JG Jr. Cholera and other vibrioses. In: Strickland GT, ed. Hunter's tropical medicine. 8th ed. Philadelphia: WB Saunders, 1999:323-34.
20. Waldor MK, Mekalanos JJ. Lysogenic conversion by a filamentous phage encoding cholera toxin. Science 1996; 272:1910-4.
21. Karaolis DK, Johnson JA, Bailey CC, Boedeker EC, Kaper JB, Reeves PR. A Vibrio cholerae pathogenicity island associated with epidemic and pandemic strains. Proc Natl Acad Sci USA 1998; 95:3134-9.
22. Merrell DS, Butler SM, Qadra F, et al. Host-induced epidemic spread of the cholera bacterium. Nature 2002; 417:642-5.
23. Franco AA, Fix AD, Prada A, et al. Cholera in Lima, Peru, correlates with prior isolation of Vibrio cholerae from the environment. Am J Epidemiol 1997; 146:1067-75.
24. Rodo X, Pascual M, Fuchs G, Faruque ASG. ENSO and cholera: a nonstationary link related to climate change. Proc Nat Acad Sci USA 2002; 99:12901-6.
25. Speelmon EC, Checkley W, Gilman RH, Patz J, Calderon M, Manga S. Cholera incidence and El-Niño-related higher ambient temperatures. JAMA 2000; 283:3072-4.
26. Blake PA, Allegra DT, Snyder JD, et al. Cholera - a possible endemic focus in the United States. N Engl J Med 1980; 302:305-9.
27. Lowry PW, Pavia AT, McFarland LM, et al. Cholera in Louisiana: widening spectrum of seafood vehicles. Arch Intern Med 1989; 149:2079-84.
28. Steinberg EB, Greene KD, Bopp CA, Cameron DN, Wells JG, Mintz ED. Cholera in the United States, 1995-2000: trends at the end of the twentieth century. J Infect Dis 2001; 184:799-802.
29. Taylor IL, Tuttle J, Pramukul T, et al. An outbreak of cholera in Maryland associated with imported commercial frozen fresh coconut milk. J Infect Dis 1993; 167:1330-5.
30. St Louis ME, Porter JD, Helal A, et al. Epidemic cholera in West Africa: the role of food handling and high-risk foods. Am J Epidemiol 1990; 131:719-28.
31. Johnston JM, Martin DL, Perdue J, et al. Cholera on a Gulf Coast oil rig. N Engl J Med 1983; 309:523-6.
32. Boyce TG, Mintz ED, Greene KD, et al. Vibrio cholerae O139 Bengal infections among tourists to Southeast Asia: an intercontinental foodborne outbreak. J Infect Dis 1995; 172:1401-4.
33. Swerdlow DL, Mintz ED, Rodriguez M, et al. Severe life-threatening cholera associated with blood group O in Peru: implications for the Latin American epidemic. J Infect Dis 1994; 170:468-72.
34. Clemens J, Albert MJ, Rao M, et al. Impact of infection by Helicobacter pylori on the risk and severity of endemic cholera. J Infect Dis 1995; 171:1653-6.
35. Gangarosa EJ, Mosley WH. Epidemiology and surveillance of cholera. In: Barua D, Burrows W, eds. Cholera. Philadelphia: WB Saunders, 1974:381-403.
36. Wang F, Butler T, Rabbani GH, Jones PK. The acidosis of cholera: contributions of hyperproteinemia, lactic acidosis, and hyperphosphatemia to an increased serum anion gap. N Engl J Med 1986; 315:1591-5.
37. World Health Organization. Management of the patient with cholera. Available at: http://www.who.int/csr/resources/publications/cholera/whocddser9115revl.pdf. Accessed on: 20 June 2003.
38. Dalsgaard A, Forslund A, Sandvang D, Arntzen L, Keddy K. Vibrio cholerae O1 outbreak isolations in Mozambique and South Africa in 1998 are multiple-drug resistant, contain the SXT element and the aadA2 gene located on class 1 integrons. J Antimicrob Chemother 2001; 48:827-38.
39. Dromigny JA, Rakoto-Alson O, Rajaonatahina D, Migliani R, Ranjalahy J, Mauclere P. Emergence and rapid spread of tetracycline-resistant Vibrio cholerae strains, Madagascar. Emerg Infect Dis 2002; 8:336-8.
40. Centers for Disease Control and Prevention. Update on cholera vaccine. Available at: http://www.cdc.gov/travel/other/cholera-vaccine.htm. Accessed on: 20 June 2003.
41. Morris JG Jr. Non-O group 1 Vibrio cholerae: a look at the epidemiology of an occasional pathogen. Epidemiol Rev 1990; 12:179-91.
42. Morris JG Jr. "Non-cholera" Vibrio species. In: Blaser MJ, Smith PD, Ravdin JI, Greenberg HB, Guerrant RL, eds. Infections of the gastrointestinal tract. 2nd ed. Philadelphia: Lippincott, Williams & Wilkins, 2002:167-9.
43. Morris JG Jr, Takeda T, Tall BD, et al. Experimental non-O group 1 Vibrio cholerae gastroenteritis in humans. J Clin Invest 1990; 85:697-705.
44. Bagchi K, Echeverria P, Arthur JD, Sethabutr O, Serichantalergs O, Hoge CW. Epidemic of diarrhea caused by Vibrio cholerae non-O1 that produced heat-stable toxin among Khmers in a camp in Thailand. J Clin Microbiol 1993; 31:1315-7.
45. Morris JG Jr, Wilson R, Davis BR, et al. Non-O group 1 Vibrio cholerae gastroenteritis in the United States: clinical, epidemiologic, and laboratory characteristics of sporadic cases. Ann Intern Med 1981; 94:656-8.
46. Safrin S, Morris JG Jr, Adams M, Pons V, Jacobs R, Conte JE Jr. Non-O:1 Vibrio cholerae bacteremia: case report and review. Rev Infect Dis 1988; 10:1012-7.
47. Chuang YC, Ko WC, Wang ST, et al. Minocycline and cefotaxime in the treatment of experimental murine Vibrio vulnificus infection. Anti-microb Agents Chemother 1998; 42:1319-22.
48. Tang HJ, Chang MC, Ko WC, Huang KY, Lee CL, Chuang YC. In vitro and in vivo activities of newer fiuoroquinolones against Vibrio vulnificus. Antimicrob Agents Chemother 2002; 46:3580-4.
49. Nishibuchi M, Fasano A, Russell RG, Kaper JB. Enterotoxigenicity of Vibrio parahaemolyticus with and without genes encoding thermostable direct hemolysin. Infect Immun 1992; 60:3539-45.
50. Yoh M, Miwatani T, Honda T. Comparison of Vibrio parahaemolyticus hemolysin (Vp-TRH) produced by clinical and environmental isolates. FEMS Microbiol Lett 1992; 71:157-61.
51. World Health Organization. Vibrio parahaemolyticus, Japan, 1996-1998. Wkly Epidemiol Rec 1999; 74:361-3.
52. Daniels NA, MacKinnon L, Bishop R, et al. Vibrio parahaemolyticus infections in the United States, 1973-1998. J Infect Dis 2000; 181:1661-6.
53. Chowdhury NR, Chakraborty S, Ramamurthy T, et al. Molecular evidence ofclonal Vibrio parahaemolyticus pandemic strains. Emerg Infect Dis 2000; 6:631-6.
54. Daniels NA, Ray B, Easton A, et al. Emergence of a new Vibrio parahaemolyticus serotype in raw oysters: a prevention quandary. JAMA 2000; 284:1541-5.
55. Hughes JM, Boyce JM, Aleem ARMA, Wells JG, Rahman ASMM, Curlin GT. Vibrio parahaemolyticus enterocolitis in Bangladesh: report of an outbreak. Am J Trop Med Hyg 1978; 27:106-12.
56. Bolen JL, Zamiska SA, Greenough WB III. Clinical features in enteritis due to Vibrio parahaemolyticus. Am J Med 1974; 57:638-41.
57. Klontz KC, Lieb S, Schreiber M, Janowski HT, Baldy LM, Gunn RA. Syndromes of Vibrio vulnificus infections: clinical and epidemiological features in Florida cases, 1981-1987. Ann Intern Meal 1988; 109:318-23.
58. Park SD, Shon HS, Job NJ. Vibrio vulnificus septicemia in Korea: clinical and epidemiologic findings in seventy patients. J Am Acad Dermatol 1991; 24:397-403.
59. Shapiro RL, Alkekruse S, Hutwagner L, et al. The role of Gulf Coast oysters harvested in warmer months in Vibrio vulnificus infections in the United States, 1988-1996. Vibrio Working Group. J Infect Dis 1998; 178:752-9.
60. Johnston JM, Becket SF, McFarland LM. Vibrio vulnificus: man and the sea. JAMA 1985; 253:2850-2.
61. Bisharat N, Agmon V, Finkelstein R, et al. Clinical, epidemiological, and microbiological features of Vibrio vulnificus biogroup 3 causing outbreaks of wound infection and bacteremia in Israel. Lancet 1999; 354:1421-4.
62. Wright AC, Simpson LM, Oliver JD, Morris JG Jr. Phenotypic evaluation of acapsular transposon mutants of Vibrio vulnificus. Infect Immun 1990; 58:1769-73.
63. Bush CA, Patel P, Gunawardena S, et al. Classification of Vibrio vulnificus strains by the carbohydrate composition of their capsular polysaccharides. Analyt Biochem 1997; 250:186-95.
64. Brennt EC, Wright AC, Dutta SK, Morris JG Jr. Growth of Vibrio vulnificus in serum from alcoholics: association with high transferrin iron saturation [letter]. J Infect Dis 1991; 164:1030-2.
65. Hor L-I, Chang T-T, Wang S-T. Survival of Vibrio vulnificus in whole blood from patients with chronic liver diseases: association with phagocytosis by neutrophils and serum ferritin levels. J Infect Dis 1999; 179:275-8.
66. Merkel SM, Alexander S, Zufall E, Oliver JD, Huet-Hudson YM. Essential role for estrogen in protection against Vibrio vulnificus-induced endotoxic shock. Infect Immun 2001; 69:6119-22.
67. Centers for Disease Control and Prevention. Vibrio vulnificus infections associated with raw oyster consumption - Florida, 1981-1992. MMWR Morb Mortal Wkly Rep 1993; 42:405-7.
68. Nilsson WB, Paranjype RH, DePaola A, Strom MS. Sequence polymorphism of the 16S rRNA gene of Vibrio vulnificus is a possible indicator of strain virulence. J Clin Microbiol 2003; 41:442-6.